BGM
BGM Group Ltd. Class A Ordinary Shares
About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Employees: 323
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
965% more capital invested
Capital invested by funds: $3.59K [Q3] → $38.2K (+$34.6K) [Q4]
50% more funds holding
Funds holding: 2 [Q3] → 3 (+1) [Q4]
0.05% more ownership
Funds ownership: 0.01% [Q3] → 0.06% (+0.05%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for BGM.
Financial journalist opinion
Based on 3 articles about BGM published over the past 30 days
Neutral
PRNewsWire
1 week ago
BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem
CHENGDU, China , May 2, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM") , a leading AI technology company, today announced it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million).
Neutral
PRNewsWire
2 weeks ago
BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform
CHENGDU, China , April 28, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) (the "Company" or BGM) today announced the completion of its acquisition of YX Management Company Ltd.
Neutral
PRNewsWire
3 weeks ago
BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy
CHENGDU, China , April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million.
Neutral
PRNewsWire
1 month ago
BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform
CHENGDU, China , March 19, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM) (NASDAQ: BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd.
Neutral
PRNewsWire
2 months ago
BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution
CHENGDU, China , Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ: BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025.
Neutral
PRNewsWire
2 months ago
BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry
CHENGDU, China , Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem.
Neutral
PRNewsWire
4 months ago
BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth
CHENGDU, China , Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, today announced completion of the acquisition of the intelligent platform of AIX Inc. It marks BGM's official entry into the domains of AI intelligent technology and financial/insurance services, opening up new opportunities for the integrated development of healthcare, pharmaceuticals, and insurance on a global scale.
Neutral
PRNewsWire
4 months ago
In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI
CHONGQING, China , Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired Rongshu Technology and Xinbao Investment Company, both subsidiaries of AIX Corp. (Stock Code: AIFU), in a transaction valued at approximately $140 million.
Neutral
PRNewsWire
4 months ago
BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development
CHENGDU, China , Dec. 19, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), Mr.
Neutral
PRNewsWire
5 months ago
AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead?
HONG KONG , Nov. 29, 2024 /PRNewswire/ -- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims services. Recently, the company has been gradually pushing for an intelligent and diversified transformation, aiming to capture growth opportunities in the AI insurance and healthcare sectors.
Charts implemented using Lightweight Charts™